Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
“Macquarie began announcing bonuses in NYC today (year-end is March 31). A lot of livid junior bankers were told only top bucket associates and analysts got paid – every one else is similar to last year’s levels. First year analysts did manage to get double last year’s class though so they were pleasantly surprised.
First year Analysts: No buckets – $20k (8 months)
Second Year Analysts: wide range with top bucket in the $60k+ range while middle bucket is ~$30k
Third year analysts: $35k middle bucket
First year Associates: No buckets – $25k (8 months)
No stub years here.”